The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013, Lancet, vol.388, pp.1081-1089, 2016. ,
Mortality rates in patients with chronic hepatitis C and cirrhosis compared with the general population: a Danish cohort study, J Infect Dis, vol.215, pp.192-201, 2017. ,
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review, Lancet Glob Health, vol.5, pp.1192-1207, 2017. ,
, Hepatitis C among drug users in Europe: epidemiology, treatment and prevention, 2016.
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs, Addiction, vol.114, pp.150-66, 2019. ,
Elimination of HCV as a public health concern among people who inject drugs by 2030-what will it take to get there?, J Int AIDS Soc, vol.20, p.22146, 2017. ,
A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design, BMC Infect Dis, vol.9, p.113, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00663624
A systematic review of hepatitis C virus treatment uptake among people who inject drugs in the European region, BMC Infect Dis, vol.14, p.16, 2014. ,
Urgent action to fight hepatitis C in people who inject drugs in Europe, Hepatol Med Policy, vol.1, issue.2, 2016. ,
Management of Mental Health Problems Prior to and during treatment of hepatitis C virus infection in patients with drug addiction, Clin Infect Dis, vol.57, pp.111-117, 2013. ,
Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among nonmedical prescription opioid users in substance use treatment: systematic review and meta-analyses, Addict Behav, vol.39, pp.520-551, 2014. ,
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large populationbased cohort, J Hepatol, vol.69, pp.1007-1021, 2018. ,
Direct-acting antiviral agents for HCV infection affecting people who inject drugs, Nat Rev Gastroenterol Hepatol, vol.14, pp.641-51, 2017. ,
The HCV epidemics in key populations (including PWID, prisoners, and MSM): the use of DAAs as treatment for prevention, Curr Opin HIV AIDS, vol.10, pp.374-80, 2015. ,
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs, Int J Drug Policy, vol.47, pp.51-60, 2017. ,
Alcohol use in opioid agonist treatment, Addict Sci Clin Pract, vol.11, p.17, 2016. ,
Engagement in care of high-risk hepatitis C Patients with interferon-free direct-acting antiviral therapies, Dig Dis Sci, vol.62, pp.1472-1481, 2017. ,
HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system, Gastroenterol Clin Biol, vol.31, pp.1074-80, 2007. ,
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users, AIDS, vol.19, p.179, 2005. ,
The natural history of hepatitis C virus infection: host, viral, and environmental factors, JAMA, vol.284, pp.450-456, 2000. ,
Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C, Am J Gastroenterol, vol.97, pp.1807-1819, 2002. ,
Mechanisms of synergy between alcohol and hepatitis C virus, J Clin Gastroenterol, vol.41, pp.761-72, 2007. ,
Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, J Hepatol, vol.67, pp.454-61, 2008. ,
Alcohol Consumption, Alcohol Dependence and Attributable Burden of Disease in Europe: Potential Gains From Effective Interventions for Alcohol Dependence ,
, American Psychological Association, p.29, 2012.
Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the 'mental health in general population' (MHGP) survey, Soc Psychiatry Psychiatr Epidemiol, vol.53, pp.567-76, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02534681
Alcohol and viral hepatitis: a mini-review, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, vol.41, pp.67-70, 2009. ,
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France), BMC Health Serv Res, vol.12, p.59, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00687514
Management of hepatitis C virus infection in heavy drinkers, Alcohol Alcohol, vol.48, pp.337-379, 2013. ,
Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents, Drug Alcohol Depend, vol.169, pp.101-110, 2016. ,
, Management of HCV with direct acting antivirals, 2016.
, Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection, p.20, 2018.
, European Monitoring Centre for Drugs and Drug Addiction. Health and social responses to drug problems: a European guide, 2017.
The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, pp.954-62, 2017. ,
Value of a national administrative database to guide public decisions: from the Système national d'information interrégimes de l' Assurance Maladie (SNIIRAM) to the Système national des données de santé (SNDS) in France, Rev Epidemiol Sante Publique, vol.65, pp.149-167, 2017. ,
Knowledge of HIV and hepatitis B and C status among people living in extreme poverty in France, Med Mal Infect, vol.45, pp.72-79, 2012. ,
Accessing hepatitis C patients who are difficult to reach: it is time to overcome barriers, J Viral Hepatol, vol.19, pp.829-864, 2012. ,
Understanding barriers to hepatitis C virus care and stigmatization from a social perspective, Clin Infect Dis, vol.57, pp.51-55, 2013. ,
Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all, Clin Infect Dis, vol.57, pp.56-61, 2013. ,
Access to care of patients with chronic hepatitis C virus infection in a university hospital: is opioid dependence a limiting condition?, Drug Alcohol Depend, vol.104, pp.78-83, 2009. ,
The stigma of alcohol dependence compared with other mental disorders: a review of population studies, Alcohol Alcohol, vol.46, pp.105-117, 2011. ,
Psychiatric disorders among at-risk consumers of alcohol in the general population, J Stud Alcohol, vol.66, pp.246-53, 2005. ,
Prone to feel guilty: self-evaluative emotions in alcoholdependence, Drug Alcohol Depend, vol.179, pp.78-82, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02536776
The relationship between DSM-IV alcohol use disorders and DSM-IV major depression: examination of the primary-secondary distinction in a general population sample, J Affect Disord, vol.38, pp.113-141, 1996. ,
Social cognition in alcoholism: a link to prefrontal cortex dysfunction?, Addiction, vol.103, pp.726-761, 2008. ,
Increased uptake of HCV testing through a community-based educational intervention in difficult-toreach people who inject drugs: results from the ANRS-AERLI study, PLOS ONE, vol.11, p.157062, 2016. ,
Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis, Eur J Epidemiol, vol.30, pp.115-144, 2015. ,
Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs, J Viral Hepatol, vol.26, pp.919-941, 2019. ,
Improving screening methods for hepatitis C among people who inject drugs: findings from the HepTLC initiative, Public Health Rep, vol.131, pp.91-98, 2012. ,
The cascade of care for an Australian community-based hepatitis C treatment service, PLOS ONE, 2019. ,
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review, Int J Drug Policy, vol.47, pp.34-46, 2017. ,
An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project, Lancet Gastroenterol Hepatol, vol.3, pp.778-89, 2018. ,
Global burden of alcoholic liver diseases, J Hepatol, vol.59, pp.160-168, 2013. ,
Alcohol control policies and alcohol consumption: an international comparison of 167 countries, J Epidemiol Community Health, vol.72, pp.54-60, 2018. ,
The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms, Am J Prev Med, vol.38, pp.217-246, 2010. ,
Evidence for the effectiveness of minimum pricing of alcohol: a systematic review and assessment using the Bradford Hill criteria for causality, BMJ Open, 2019. ,
Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy, Aliment Pharmacol Ther, vol.43, pp.674-96, 2016. ,
Effectiveness of Simeprevir plus Sofosbuvir, with or without ribavirin, in real-world patients with HCV genotype 1 infection, Gastroenterology, vol.150, pp.419-448, 2016. ,
Interferon-free, directacting antiviral therapy for chronic hepatitis C, J Viral Hepatol, vol.22, pp.861-70, 2015. ,
Rapid and large-scale implementation of HCV treatment advances in France, BMC Infect Dis, vol.17, p.784, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-02048136
, French Ministry of Social Affairs and Health. Decree [Arrêté du 10 juin 2016 relatif aux conditions de prise en charge de spécialités pharmaceutiques disposant d'une autorisation de mise sur le marché inscrites sur la liste visée à l'article L. 5126-4 du code de la santé publique
Direct antiviral agent treatment of decompensated hepatitis C virus-induced liver cirrhosis, World J Gastrointest Pharmacol Ther, vol.6, pp.114-123, 2015. ,
, National observatory of the urban policy, p.25, 2015.
Equity of primary care service delivery for low income 'sicker' adults across 10 OECD countries, Int J Equity Health [internet, vol.17, p.182, 2018. ,
Efforts at the frontlines: implementing a hepatitis C testing and linkage-to-care program at the local public health level, Public Health Rep, vol.131, pp.57-64, 2016. ,
Increasing trends in screening for addictives behaviors among general practitioners in France, Rev Epidemiol Sante Publique, vol.59, pp.285-94, 2011. ,
Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment, Eur Addict Res, vol.21, pp.78-87, 2015. ,
Excessive alcohol consumption is associated with reduced quality of life among methadone patients, Addiction, vol.102, pp.257-63, 2006. ,
Correlates of depressive symptoms among alcohol-using methadone maintained adults, Am J Addict, vol.21, pp.49-55, 2012. ,